Todd Juan

7.4k total citations · 1 hit paper
47 papers, 5.7k citations indexed

About

Todd Juan is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Todd Juan has authored 47 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 12 papers in Oncology and 11 papers in Immunology. Recurrent topics in Todd Juan's work include Colorectal Cancer Treatments and Studies (7 papers), Glycosylation and Glycoproteins Research (4 papers) and Complement system in diseases (4 papers). Todd Juan is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Glycosylation and Glycoproteins Research (4 papers) and Complement system in diseases (4 papers). Todd Juan collaborates with scholars based in United States, Italy and Belgium. Todd Juan's co-authors include Daniel J. Freeman, Robert Radinsky, Rafael G. Amado, Scott D. Patterson, Sid Suggs, Michael Wolf, Marc Peeters, Robert Sikorski, David Chang and Eric Van Cutsem and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Todd Juan

46 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer

2008 2.4k citations Rafael G. Amado, Michael Wolf et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Todd Juan

Since Specialization

Citations

This map shows the geographic impact of Todd Juan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd Juan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd Juan more than expected).

Fields of papers citing papers by Todd Juan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todd Juan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd Juan. The network helps show where Todd Juan may publish in the future.

Co-authorship network of co-authors of Todd Juan

This figure shows the co-authorship network connecting the top 25 collaborators of Todd Juan. A scholar is included among the top collaborators of Todd Juan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todd Juan. Todd Juan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sclerostin expression is induced by BMPs in human Saos-2 osteosarcoma cells but not via direct effects on the sclerostin gene promoter or ECR5 element 2011 ·Bone ·(unknown), (unknown), Jin Cao, Chun-Ya Han, Todd Juan, Michael Bass, Chetan Deshpande, Michael A. Damore, Richard J. Stanton, Philip Babij	27
2	FusionMap: detecting fusion genes from next-generation sequencing data at base-pair resolution 2011 ·Bioinformatics ·Huanying Ge, Kejun Liu, Todd Juan, Fang Fang, (unknown), W Hoeck	182
3	Biochemical Characterization of AMG 102: A Neutralizing, Fully Human Monoclonal Antibody to Human and Nonhuman Primate Hepatocyte Growth Factor 2010 ·Molecular Cancer Therapeutics ·Teresa L. Burgess, Jan Sun, Susanne Meyer, Trace S. Tsuruda, Jilin Sun, Gary Elliott, Qing Chen, Mitsuru Haniu, (unknown), Todd Juan, Ke Zhang, Angela Coxon, Richard Kendall	68
4	Motesanib inhibits Kit mutations associated with gastrointestinal stromal tumors 2010 ·Journal of Experimental & Clinical Cancer Research ·Sean Caenepeel, Lisa Renshaw-Gegg, (unknown), Tammy L. Bush, (unknown), Todd Juan, Raffi Manoukian, Andrew S. Tasker, Anthony Polverino, Paul E. Hughes	15
5	Phase II Study of Safety and Efficacy of Motesanib in Patients With Progressive or Symptomatic, Advanced or Metastatic Medullary Thyroid Cancer 2009 ·Journal of Clinical Oncology ·Martin Schlumberger, Rossella Elisei, Lars Bastholt, Lori J. Wirth, Renato Martins, Laura D. Locati, Barbara Jarząb, Furio Pacini, Chantal Daumerie, Jean-Pierre Droz, Michael Eschenberg, Yu-Nien Sun, Todd Juan, Daniel E. Stepan, Steven I. Sherman	257
6	Targeted deletion of Nm23/nucleoside diphosphate kinase A and B reveals their requirement for definitive erythropoiesis in the mouse embryo 2009 ·Developmental Dynamics ·Edith H. Postel, (unknown), Xiaoming Zou, Todd Juan, Ning Sun, Diane D’Agostin, (unknown), (unknown), Daniel A. Notterman, Krista M. D. La Perle	34
7	Pancreatic islet expression profiling in diabetes-prone C57BLKS/J mice reveals transcriptional differences contributed by DBA loci, including Plagl1 and Nnt 2009 ·PubMed ·Abraham Anderson, Joan Helmering, Todd Juan, Chi-Ming Li, (unknown), Melissa Graham, (unknown), Michael A. Damore, Murielle M. Véniant, David J. Lloyd	31
8	Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer breakdown → 2008 ·Journal of Clinical Oncology ·Rafael G. Amado, Michael Wolf, Marc Peeters, Eric Van Cutsem, Salvatore Siena, Daniel J. Freeman, Todd Juan, Robert Sikorski, Sid Suggs, Robert Radinsky, Scott D. Patterson, David Chang	2400
9	Association of somatic kRAS gene mutations and clinical outcome from a phase 2 mCRC trial of panitumumab 2007 ·Clinical Cancer Research ·Todd Juan, Dan Freeman, Ildiko Sarosi, (unknown), (unknown), (unknown), Robert Radinsky	1
10	AMG 479, a fully human anti IGF-1 receptor monoclonal antibody, is efficacious against Ewing’s sarcoma and osteosarcoma xenografts 2007 ·Molecular Cancer Therapeutics ·Gordon Moody, Petia Mitchell, Elaina Cajulis, (unknown), Tibor Gyuris, Todd Juan, Robert Radinsky, Frank J. Calzone, Pedro J. Beltran	6
11	Generation and Characterization of Monoclonal Antibodies to Human Keratinocyte Growth Factor Receptor 2006 ·Hybridoma ·Ping Wei, Jinghui Zhan, Shuying Liu, David Chang, Raj Haldankar, (unknown), (unknown), John O. Hui, Todd Juan, Jane Talvenheimo, Helen Kim, Luke Li, T. Boone, Luís Borges	3
12	Epratuzumab, a Humanized Monoclonal Antibody Targeting CD22 2003 ·Clinical Cancer Research ·Josette Carnahan, Paul Wang, Richard Kendall, Ching Chen, Sylvia Hu, T. Boone, Todd Juan, Jane Talvenheimo, Silvia Montestruque, Jilin Sun, Gary Elliott, John Thomas, John Ferbas, Brent Kern, Robert Briddell, John P. Leonard, Alessandra Cesano	5
13	The Dual Specificity JKAP Specifically Activates the c-Jun N-terminal Kinase Pathway 2002 ·Journal of Biological Chemistry ·Alice Chen, Guisheng Zhou, Todd Juan, (unknown), John P. Cannon, (unknown), Christian F. Meyer, Roland Jurecic, Neal G. Copeland, Debra J. Gilbert, Nancy A. Jenkins, (unknown), Tse‐Hua Tan, John W. Belmont	81
14	Osteoprotegerin Ligand Modulates Murine Osteoclast Survival in Vitro and in Vivo 2000 ·American Journal Of Pathology ·David L. Lacey, Hong Tan, John Lu, Steven L. Kaufman, Gwyneth Van, (unknown), (unknown), Sheila Scully, Frederick A. Fletcher, Todd Juan, Michael J. Kelley, Teresa L. Burgess, William J. Boyle, Anthony Polverino	321
15	Identification and Mapping ofCasp7,a Cysteine Protease Resembling CPP32β, Interleukin-1β Converting Enzyme, and CED-3 1997 ·Genomics ·Todd Juan, Ian McNiece, (unknown), Nancy A. Jenkins, Debra J. Gilbert, Neal G. Copeland, Frederick A. Fletcher	31
16	cDNA cloning and chromosomal mapping of mouse fast skeletal muscle troponin T 1997 ·Mammalian Genome ·Anne Koch, Todd Juan, Nancy A. Jenkins, Debra J. Gilbert, Neal G. Copeland, Ian McNiece, Frederick A. Fletcher	4
17	Molecules from Staphylococcus aureus that bind CD14 and stimulate innate immune responses. 1995 ·The Journal of Experimental Medicine ·Takashi Kusunoki, Eric Hailman, Todd Juan, Henri S. Lichenstein, Samuel D. Wright	149
18	DNA binding by C/EBP proteins correlates with hepatocyte proliferation 1995 ·In Vitro Cellular & Developmental Biology - Animal ·Humberto E. Soriano, (unknown), Todd Juan, Wei Zhao, Gretchen J. Darlington	14
19	Identification of a Domain in Soluble CD14 Essential for Lipopolysaccharide (LPS) Signaling but Not LPS Binding 1995 ·Journal of Biological Chemistry ·Todd Juan, Eric Hailman, Michael J. Kelley, Samuel D. Wright, Henri S. Lichenstein	57
20	A 58-Base-Pair Region of the Human C3 Gene Confers Synergistic Inducibility by Interleukin-1 and Interleukin-6 1990 ·Molecular and Cellular Biology ·Debra Rose Wilson, Todd Juan, Margaret Wilde, Georg H. Fey, Gretchen J. Darlington	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact